Enovis™ Announces Leadership Transition in Surgical Division
Enovis™, a prominent global medical technology innovator, has recently revealed a pivotal change in its leadership. Davide Visentin will take the helm as President of Enovis International Surgical, effective March 1. His appointment signals an exciting new chapter for the company, known for its commitment to enhancing patient outcomes and innovation in orthopedics.
Meet Davide Visentin: A Leader with Vast Experience
Davide Visentin comes to Enovis with a wealth of experience in the healthcare industry, boasting over 20 years in MedTech. His previous role as Vice President and General Manager of the Integrated Diagnostic Solutions Business Unit at BD showcased his ability to lead effectively, overseeing a team of 700 employees across 50 countries. Visentin's strategic foresight allowed him to gain significant market share within a competitive landscape.
Before his tenure at BD, Davide demonstrated his leadership skills at Stryker, where he managed the company's Joint Replacement and Robotic Division in Europe as Vice President and General Manager. His experience at Johnson & Johnson Depuy Synthes as Vice President, EMEA, further solidifies his credentials as a knowledgeable leader in the medical field.
Acknowledgment of Benjamin Reinmann’s Contributions
Louie Vogt, Group President of Enovis’ Reconstructive Business Group, expressed heartfelt gratitude towards Benjamin Reinmann for his remarkable contributions during his leadership. Under Reinmann’s stewardship, Enovis developed a world-class International Surgical Business. His work facilitated the smooth integration of legacy companies, namely Mathys and LimaCorporate.
Visentin’s Vision for Enovis
In his new role, Visentin aims to leverage his robust experience and passion for orthopedics to elevate Enovis to new heights. He holds a degree in Computer Science from the University of Milan and will spend considerable time at locations in Villanova, Italy, and Bettlach, Switzerland. His strategic vision aligns with the commitment to innovation and excellence that Enovis strives for every day.
“With the dedication of our team, we are reshaping our International Surgical Business into a global leader in orthopedics. Our ongoing focus is to create value through teamwork and innovation,” stated Vogt. “The solid foundations established in previous years have positioned us to advance our strategic objectives, increasing market presence and driving growth by enhancing patient care.”
About Enovis™
Enovis™ (NYSE: ENOV) is committed to making a meaningful impact on lives worldwide through innovative medical technology solutions. By partnering with healthcare's brightest minds, Enovis is dedicated to delivering smarter and more effective care. The company’s solutions are designed to enhance operational efficiency for surgeons and clinicians while significantly improving patient outcomes.
Frequently Asked Questions
Who is Davide Visentin?
Davide Visentin is the newly appointed President of Enovis International Surgical, effective March 1.
What is Enovis™ known for?
Enovis™ is recognized for its innovative medical technology solutions that enhance patient outcomes in orthopedics.
What experience does Visentin bring to his new role?
Visentin has over 20 years of experience in healthcare, having previously held leadership positions at BD, Stryker, and Johnson & Johnson.
How did Louie Vogt describe the transition?
Vogt expressed excitement about Visentin's arrival and appreciation for Reinmann’s contributions, highlighting the momentum for future growth.
What is the focus of Enovis™ moving forward?
Enovis™ aims to continue building its International Surgical Business into a global orthopedics leader through innovation and market expansion.
